Soleno Therapeutics logo

Soleno Therapeutics Share Price Today

(NASDAQ: SLNO)

Soleno Therapeutics share price is $44.99 & ₹3,912.74 as on 6 Mar 2025, 2.30 'hrs' IST

$44.99

0.55

(1.24%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Soleno Therapeutics share price in Dollar and Rupees. Guide to invest in Soleno Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Soleno Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Soleno Therapeutics share price movements

  • Today's Low: $43.40
    Today's High: $45.75

    Day's Volatility :5.14%

  • 52 Weeks Low: $36.61
    52 Weeks High: $60.92

    52 Weeks Volatility :39.9%

Soleno Therapeutics (SLNO) Returns

PeriodSoleno Therapeutics IncIndex (Russel 2000)
3 Months
-10.49%
0.0%
6 Months
-10.97%
0.0%
1 Year
-4.18%
0.0%
3 Years
886.9%
-11.6%

Soleno Therapeutics (SLNO) Key Statistics

in dollars & INR

Previous Close
$44.44
Open
$45.23
Today's High
$45.75
Today's Low
$43.4
Market Capitalization
$2.1B
Today's Volume
$365.6K
52 Week High
$60.92
52 Week Low
$36.61
Revenue TTM
$0.0
EBITDA
$-182.5M
Earnings Per Share (EPS)
$-4.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-87.35%

How to invest in Soleno Therapeutics Stock (SLNO) from India?

It is very easy for Indian residents to invest directly in Soleno Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Soleno Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Soleno Therapeutics or SLNO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Soleno Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Soleno Therapeutics shares which would translate to 0.019 fractional shares of Soleno Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Soleno Therapeutics, in just a few clicks!

Returns in Soleno Therapeutics (SLNO) for Indian investors in Rupees

The Soleno Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Soleno Therapeutics investment value today

Current value as on today

₹1,01,966

Returns

₹1,966

(+1.97%)

Returns from Soleno Therapeutics Stock

₹2,997 (-3%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Soleno Therapeutics (SLNO)

-13%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Soleno Therapeutics Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Soleno Therapeutics

  • Vivo Capital, LLC

    13.72%

  • HHG PLC

    11.31%

  • Nantahala Capital Management, LLC

    8.57%

  • Adage Capital Partners Gp LLC

    6.05%

  • venBio Select Advisor LLC

    5.51%

  • BlackRock Inc

    4.38%

Analyst Recommendation on Soleno Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Soleno Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Soleno Therapeutics Stock (SLNO)

What analysts predicted

Upside of 65.12%

Target:

$74.29

Current:

$44.99

Insights on Soleno Therapeutics Stock (Ticker Symbol: SLNO)

  • Price Movement

    In the last 3 years, SLNO stock has moved up by 852.9%
  • SLNO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 64.4%

Soleno Therapeutics Technicals Summary

Sell

Neutral

Buy

Soleno Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Soleno Therapeutics (SLNO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Soleno Therapeutics Inc logo
-8.41%
-10.97%
-4.18%
886.9%
3.23%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Soleno Therapeutics Inc logo
NA
NA
0.0
0.0
-0.87
-0.45
NA
5.36
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Soleno Therapeutics Inc logo
Buy
$2.1B
3.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Soleno Therapeutics

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Organization
Soleno Therapeutics
Employees
0
CEO
Dr. Anish Bhatnagar M.D.
Industry
Health Technology

Management People of Soleno Therapeutics

NameTitle
Dr. Anish Bhatnagar M.D.
President, CEO, COO & Director
Ms. Patricia C. Hirano M.P.H.
Senior Vice President of Regulatory Affairs
Mr. Jesse Schumaker
General Counsel
Ms. Lauren Budesheim
Vice President of People
Ms. Kristen Yen M.S.
Senior Vice President of Clinical Operations
Dr. Neil M. Cowen M.B.A., Ph.D.
Senior Vice President of Drug Development
Ms. Meredith Manning M.B.A.
Chief Commercial Officer
Dr. Michael Huang M.D.
Senior Vice President of Clinical Development

Important FAQs about investing in SLNO Stock from India :

What is Soleno Therapeutics share price today?

Soleno Therapeutics share price today stands at $44.99, Open: $45.23 ; Previous Close: $44.44 ; High: $45.75 ; Low: $43.40 ; 52 Week High: $60.92 ; 52 Week Low: $36.61.

The stock opens at $45.23, after a previous close of $44.44. The stock reached a daily high of $45.75 and a low of $43.40, with a 52-week high of $60.92 and a 52-week low of $36.61.

Can Indians buy Soleno Therapeutics shares?

Yes, Indians can invest in the Soleno Therapeutics (SLNO) from India.

With INDmoney, you can buy Soleno Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Soleno Therapeutics at zero transaction cost.

How can I buy Soleno Therapeutics shares from India?

It is very easy to buy Soleno Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Soleno Therapeutics (SLNO) be purchased?

Yes, you can buy fractional shares of Soleno Therapeutics with INDmoney app.

What are the documents required to start investing in Soleno Therapeutics stocks?

To start investing in Soleno Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Soleno Therapeutics Stock (SLNO)?

Today’s highest price of Soleno Therapeutics (SLNO) is $45.75.

Today’s lowest price of Soleno Therapeutics (SLNO) is $43.40.

What is today's market capitalisation of Soleno Therapeutics?

Today's market capitalisation of Soleno Therapeutics SLNO is 2.1B

What is the 52 Week High and Low Range of Soleno Therapeutics Stock (SLNO)?

  • 52 Week High

    $60.92

  • 52 Week Low

    $36.61

What are the historical returns of Soleno Therapeutics (SLNO)?

  • 1 Month Returns

    -8.41%

  • 3 Months Returns

    -10.97%

  • 1 Year Returns

    -4.18%

  • 5 Years Returns

    3.23%

Who is the Chief Executive Officer (CEO) of Soleno Therapeutics ?

Dr. Anish Bhatnagar M.D. is the current Chief Executive Officer (CEO) of Soleno Therapeutics.